Cambridge Research & Innovation

Cambridge Research & Innovation (CR&I) is a specialist venture management and innovation consultancy based in Cambridge, UK. The firm is historically significant for its pivotal role in catalyzing the Cambridge biotech cluster by providing seed funding and strategic management to high-potential university spin-outs. CR&I was instrumental in the foundation of several landmark biotechnology companies, most notably Cambridge Antibody Technology (CAT), Chiroscience, and Xenova. The company's core business involves bridging the gap between academic research and commercial application through technology development, intellectual property management, and venture creation. Today, CR&I continues to support researchers and corporate clients in the life sciences, materials, and physical sciences sectors. The firm operates on a 'venture management' model, often providing interim leadership for the startups it helps create.